Spyre Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Spyre Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2015 to Q3 2024.
  • Spyre Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 51.4M shares, a 1169% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 51.4M +47.3M +1169% Sep 30, 2024 10-Q/A 2024-11-18
Q2 2024 50.8M -30.2M -37.3% Jun 30, 2024 10-Q/A 2024-11-18
Q1 2024 36.6M -28.8M -44% Mar 31, 2024 10-Q/A 2024-11-18
Q4 2023 36.1M +33.4M +1279% Dec 31, 2023 10-Q/A 2024-11-18
Q3 2023 4.05M -57.5M -93.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 81M +19.8M +32.4% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 65.4M +16M +32.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 2.61M -46.7M -94.7% Dec 31, 2022 10-K/A 2024-11-18
Q3 2022 61.5M +12.2M +24.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 61.2M +12.1M +24.8% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 49.4M +400K +0.82% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 49.4M +1.4M +2.91% Dec 31, 2021 10-K 2023-03-02
Q3 2021 49.3M +4.61M +10.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 49M +4.43M +9.92% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 49M +19.9M +68.2% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 48M +18.9M +64.9% Dec 31, 2020 10-K 2022-03-08
Q3 2020 44.7M +15.8M +54.5% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 44.6M +15.8M +54.6% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 29.1M +310K +1.08% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 29.1M +4.94M +20.5% Dec 31, 2019 10-K 2021-03-18
Q3 2019 28.9M +6.83M +30.9% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 28.8M +6.94M +31.7% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 28.8M +12M +71.6% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 24.1M +7.47M +44.8% Dec 31, 2018 10-K 2020-02-24
Q3 2018 22.1M +5.63M +34.1% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 21.9M +5.46M +33.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 16.8M +3.36M +25% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 16.7M +3.24M +24.1% Dec 31, 2017 10-K 2019-03-07
Q3 2017 16.5M +3.04M +22.6% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 16.5M +3.04M +22.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 13.5M +12.7M +1676% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 13.4M +12.7M +1673% Dec 31, 2016 10-K 2018-03-13
Q3 2016 13.4M Sep 30, 2016 10-Q 2016-11-09
Q2 2016 13.4M Jun 30, 2016 10-Q 2016-08-09
Q1 2016 757K Mar 31, 2016 10-Q 2016-05-19
Q4 2015 757K Dec 31, 2015 10-K 2017-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.